Lexaria Bioscience
Quarterly Financials
| Values in thousands | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 |
|---|---|---|---|---|
Revenue | $174 | $174 | $183 | $84 |
Gross Profit | 174 | 174 | 181 | 84 |
EBITDA | -3,750 | -2,751 | -2,690 | -2,203 |
EBIT | -2,195 | |||
Net Income | -3,789 | -2,713 | -2,703 | -2,184 |
Net Change In Cash | 174 | 174 | 183 | 84 |
Free Cash Flow | -3,583 | -1,497 | -2,726 | -1,961 |
Cash | 4,591 | 6,468 | 8,078 | 6,499 |
Basic Shares | 18,298 | 17,511 | 16,668 | 13,119 |
Annual Financials
| Values in thousands | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|---|
Revenue | $464 | $226 | $255 | $722 |
Gross Profit | 459 | 194 | 183 | 547 |
EBITDA | -5,676 | -6,388 | -6,516 | -5,575 |
EBIT | -5,753 | -6,534 | -6,663 | -5,722 |
Net Income | -5,795 | -6,664 | -7,269 | -2,504 |
Net Change In Cash | 464 | 226 | 255 | 722 |
Free Cash Flow | -5,002 | -6,050 | -5,010 | -4,069 |
Cash | 6,499 | 1,352 | 5,813 | 10,917 |
Basic Shares | 12,383 | 6,614 | 5,885 | 4,391 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-08-31 | $0 |
2025-05-31 | -$0.21 |
2025-02-28 | -$0.15 |
2024-11-30 | -$0.16 |
